FDA Approved: EVAMIST — Supplemental Application (Padagis US LLC)

View source ↗

Summary

The FDA approved a supplemental application for Evamist (estradiol) submitted by Padagis US LLC, as part of an additional regulatory action.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasomotor Symptoms Due to Menopause

Drugs mentioned

• EVAMIST (ESTRADIOL)

Snippet

SUPPL AP for EVAMIST (ESTRADIOL)